IDEXX Net Income From Continuing Ops from 2010 to 2025
| IDXX Stock | USD 415.87 6.67 1.58% |
Net Income From Continuing Ops | First Reported 2000-03-31 | Previous Quarter 232.8 M | Current Value 216.1 M | Quarterly Volatility 73.3 M |
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.4 M, Interest Expense of 32.8 M or Total Revenue of 4.1 B, as well as many indicators such as Price To Sales Ratio of 9.17, Dividend Yield of 0.0 or PTB Ratio of 22.4. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
IDEXX | Net Income From Continuing Ops |
Latest IDEXX Laboratories' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of IDEXX Laboratories over the last few years. It is IDEXX Laboratories' Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
IDEXX Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 415,607,949 | |
| Geometric Mean | 348,252,389 | |
| Coefficient Of Variation | 60.80 | |
| Mean Deviation | 211,190,568 | |
| Median | 377,047,000 | |
| Standard Deviation | 252,704,718 | |
| Sample Variance | 63859.7T | |
| Range | 746.5M | |
| R-Value | 0.84 | |
| Mean Square Error | 19956.8T | |
| R-Squared | 0.71 | |
| Significance | 0.000044 | |
| Slope | 44,672,011 | |
| Total Sum of Squares | 957895.1T |
IDEXX Net Income From Continuing Ops History
About IDEXX Laboratories Financial Statements
IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 887.9 M | 454.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.